Real-time index price for Nasdaq Health Care Index (IXHC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

To say that pharmaceutical giant Novo Nordisk (NYSE: NVO) has had a tumultuous relationship with telehealth company Hims & Hers Health (NYSE: HIMS) in the past year would be a bit of an understatement ...

Pre-earnings rally: Shares rose 4.95% to $29.71 as traders positioned for Q1 results due after Monday’s market close. Growth and partnerships: New care offerings, international acquisitions, and the ...

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors pile into the stock ahead of a May 11 earnings report. The move caps a ...

Digital health firm Hims & Hers' stock plummeted on Tuesday on weak first-quarter earnings. Hims reported a net loss of $92 million in the first quarter, up from $50 million last year. The company ...

Hims & Hers Health (HIMS) reported Q1 2026 earnings on May 11 and the stock dropped. Revenue of $608.1 million missed the $616.9 million estimate. The GAAP loss came in at $0.40 per share, far below ...

Hims & Hers Health (HIMS) reported its 1Q26 earnings after the bell on Monday, marking the company's first quarterly earnings report since it closed a deal with Novo Nordisk (NOV) in early March. HIMS ...